Literature DB >> 20858853

An accompanying genetic severe deficiency of tissue factor protects mice with a protein C deficiency from lethal endotoxemia.

Francis J Castellino1, Deborah L Donahue, Rudolph M Navari, Victoria A Ploplis, Mark Walsh.   

Abstract

Mice with a severe genetic deficiency of protein C (PC), PC(-/-)PC(tg4), display enhanced susceptibility to lethal effects of gram-negative endotoxemia induced by lipopolysaccharide (LPS), whereas mice severely deficient in tissue factor (TF), TF(-/-)hTF(tg), are protected from LPS-mediated lethality. In this study, we show that a simultaneous severe deficiency of TF protected low-PC mice from LPS-induced death, resulting in a survival profile similar to that experienced by wild-type (WT) mice. Plasma and whole blood coagulation assays, the latter measured by thromboelastography, demonstrated development of coagulopathies in LPS-treated mice, which were more severe in the case of the doubly deficient TF(-/-)hTF(tg)/PC(-/-)PC(tg4) mice, mainly reflecting earlier signs of disseminated intravascular coagulation in this latter cohort. Markers of inflammation were also elevated in response to LPS in both groups of mice at times just preceding death. We conclude that whereas coagulopathies are more exacerbated in LPS-treated TF(-/-)hTF(tg)/PC(-/-)PC(tg4) mice, the lowering of TF levels in mice with an accompanying severe PC deficiency confers protection against death compared with mice with a single severe PC deficiency. This suggests that proteases generated as a result of factor VIIa/TF-mediated thrombin generation play a mechanistic role in the enhanced lethality seen under very low PC conditions in an endotoxemia model in mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20858853      PMCID: PMC3037749          DOI: 10.1182/blood-2010-07-299057

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  Efficacy and safety of recombinant human activated protein C for severe sepsis.

Authors:  G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

2.  Optimizing thrombelastography (TEG) assay conditions to monitor rFVIIa (NovoSeven) therapy in haemophilia A patients.

Authors:  Dorthe Viuff; Søren Andersen; Brit B Sørensen; Stefan Lethagen
Journal:  Thromb Res       Date:  2010-06-09       Impact factor: 3.944

3.  A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice.

Authors:  V A Ploplis; J Wilberding; L McLennan; Z Liang; I Cornelissen; M E DeFord; E D Rosen; F J Castellino
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

Review 4.  Thrombin signalling and protease-activated receptors.

Authors:  S R Coughlin
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

5.  Blockade of tissue factor: treatment for organ injury in established sepsis.

Authors:  Martha Sue Carraway; Karen E Welty-Wolf; Debra L Miller; Thomas L Ortel; Steven Idell; Andrew J Ghio; Lars C Petersen; Claude A Piantadosi
Journal:  Am J Respir Crit Care Med       Date:  2003-05-01       Impact factor: 21.405

Review 6.  The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications.

Authors:  Silvio Danese; Stefania Vetrano; Li Zhang; Victoria A Poplis; Francis J Castellino
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

7.  The thrombomodulin-protein C system is essential for the maintenance of pregnancy.

Authors:  Berend Isermann; Rashmi Sood; Rafal Pawlinski; Mark Zogg; Shawn Kalloway; Jay L Degen; Nigel Mackman; Hartmut Weiler
Journal:  Nat Med       Date:  2003-02-10       Impact factor: 53.440

8.  Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia.

Authors:  Rafal Pawlinski; Brian Pedersen; Gernot Schabbauer; Michael Tencati; Todd Holscher; William Boisvert; Patricia Andrade-Gordon; Rolf Dario Frank; Nigel Mackman
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

9.  Coagulopathy and traumatic shock: characterizing hemostatic function during the critical period prior to fluid resuscitation.

Authors:  Nathan J White; Erika J Martin; Donald F Brophy; Kevin R Ward
Journal:  Resuscitation       Date:  2009-10-24       Impact factor: 5.262

10.  Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality.

Authors:  Jian-Ming Gu; James T B Crawley; Gary Ferrell; Fangjiu Zhang; Weihong Li; Naomi L Esmon; Charles T Esmon
Journal:  J Biol Chem       Date:  2002-09-05       Impact factor: 5.157

View more
  4 in total

1.  Host defense peptides of thrombin modulate inflammation and coagulation in endotoxin-mediated shock and Pseudomonas aeruginosa sepsis.

Authors:  Martina Kalle; Praveen Papareddy; Gopinath Kasetty; Matthias Mörgelin; Mariena J A van der Plas; Victoria Rydengård; Martin Malmsten; Barbara Albiger; Artur Schmidtchen
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

2.  Genetic variation in the tissue factor gene is associated with clinical outcome in severe sepsis patients.

Authors:  Dongwei Shi; Zhenju Song; Jun Yin; Mingming Xue; Chenling Yao; Zhan Sun; Mian Shao; Zhi Deng; Yaping Zhang; Zhengang Tao; Si Sun; Jin Zhang; Lingyu Xing; Zhimin Dong; Yuxin Wang; Chaoyang Tong
Journal:  Crit Care       Date:  2014-11-17       Impact factor: 9.097

3.  Amelioration of Coagulation Disorders and Inflammation by Hydrogen-Rich Solution Reduces Intestinal Ischemia/Reperfusion Injury in Rats through NF-κB/NLRP3 Pathway.

Authors:  Ling Yang; Yan Guo; Xin Fan; Ye Chen; Bo Yang; Ke-Xuan Liu; Jun Zhou
Journal:  Mediators Inflamm       Date:  2020-06-10       Impact factor: 4.711

4.  Abnormal whole blood thrombi in humans with inherited platelet receptor defects.

Authors:  Francis J Castellino; Zhong Liang; Patrick K Davis; Rashna D Balsara; Harsha Musunuru; Deborah L Donahue; Denise L Smith; Mayra J Sandoval-Cooper; Victoria A Ploplis; Mark Walsh
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.